Spectral Gross Profit from 2010 to 2024

EDT Stock  CAD 0.53  0.03  6.00%   
Spectral Med Gross Profit yearly trend continues to be very stable with very little volatility. Gross Profit is likely to grow to about -4.6 M this year. Gross Profit is the profit Spectral Med makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals
 
Gross Profit  
First Reported
1992-06-30
Previous Quarter
-919 K
Current Value
-2.1 M
Quarterly Volatility
833.7 K
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Spectral Med financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Spectral Med's main balance sheet or income statement drivers, such as Depreciation And Amortization of 207.1 K, Interest Expense of 1.4 M or Selling General Administrative of 8.1 M, as well as many indicators such as Price To Sales Ratio of 45.68, Dividend Yield of 0.0 or Days Sales Outstanding of 40.36. Spectral financial statements analysis is a perfect complement when working with Spectral Med Valuation or Volatility modules.
  
This module can also supplement various Spectral Med Technical models . Check out the analysis of Spectral Med Correlation against competitors.

Pair Trading with Spectral Med

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Spectral Med position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spectral Med will appreciate offsetting losses from the drop in the long position's value.

Moving against Spectral Stock

  0.85WMT Walmart Inc CDRPairCorr
  0.77META Meta Platforms CDRPairCorr
  0.75TSLA Tesla Inc CDRPairCorr
  0.73AMZN Amazon CDRPairCorr
  0.71NVDA NVIDIA CDRPairCorr
The ability to find closely correlated positions to Spectral Med could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Spectral Med when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Spectral Med - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Spectral Med to buy it.
The correlation of Spectral Med is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Spectral Med moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Spectral Med moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Spectral Med can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Spectral Stock

Spectral Med financial ratios help investors to determine whether Spectral Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Spectral with respect to the benefits of owning Spectral Med security.